EU Working To Increase Rx-to-OTC Switches Through Centralized Procedure
This article was originally published in The Tan Sheet
Executive Summary
Despite the availability of a centralized procedure for Rx-to-OTC switches in the European Union, member states and stakeholders in the drug industry are still working toward streamlining regulatory and approval processes, and working toward the development of a single market
You may also be interested in...
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation
Commercialization Phase Brings New Challenges To Nanotech Industry
Increased industry/government collaboration is needed in the field of nanotechnology to move out of the research and development phase and into the commercialization phase, speakers told the President's Council of Advisors on Science and Technology during a June 25 meeting